{"id":"W2261816221","doi":"10.1183/13993003/erj.38.suppl_55.3427","title":"NVA237 once daily reduces the percentage of patients with exacerbations of COPD and associated hospitalizations: The GLOW1 trial","year":2011,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Exacerbation; Placebo; Confidence interval; Internal medicine; Hazard ratio; Bronchodilator; Odds ratio; Randomized controlled trial; Dry-powder inhaler; Clinical endpoint; Anesthesia; Inhaler; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008364605,0.0007522173,0.001722452,0.0001598298,0.0001481332,0.0007556997,0.0006327529,0.0008242606,0.00314035],"category_scores_gemma":[0.0007064544,0.0002042501,0.001333354,0.0001909744,0.0004074517,0.0003164282,0.000309866,0.001225905,0.0005355319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003663998,"about_ca_system_score_gemma":0.0005049374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007510183,"about_ca_topic_score_gemma":0.001830972,"domain_scores_codex":[0.9996675,0.0001989513,0.00001576364,0.00004821042,0.00002806666,0.0000415202],"domain_scores_gemma":[0.9996312,0.0000980401,0.0001192228,0.00002599291,0.00001847242,0.0001071778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.837615,0.002914439,0.009339502,0.0042029,0.006410357,0.0001986087,0.0001091891,0.001644296,0.01036305,0.0004794771,0.00862484,0.1180984],"study_design_scores_gemma":[0.8301969,0.1020367,0.05001431,0.0005799448,0.006135704,0.0004656024,0.0001406189,0.002090068,0.001955406,0.0008300428,0.005461241,0.00009354801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733183,0.0221331,0.0001619057,0.001112218,0.0001810445,0.0003036925,0.001324211,0.00006785608,0.001397823],"genre_scores_gemma":[0.9860036,0.007750819,0.0003570964,0.0010596,0.0002883123,0.0006772965,0.001443085,0.00001771361,0.002402589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00314035,"threshold_uncertainty_score":0.01050556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03248581757925097,"score_gpt":0.2723007685844323,"score_spread":0.2398149510051814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}